{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04833",
    "Peptide Name": "[Lys4, Ala13] brevinine-1pl (brevinine-1pl I4K,L13A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a)",
    "Source": "amino acid substitution, amphibians, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FFPKVAGVAAKVAKKIFCTISKKC",
    "Sequence Length": 24,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal",
      "Anti-MRSA",
      "Hemolytic"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": -0.09,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "58%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is unique and shows only very low similarity (91.67%) tobrevinine-1plK: 25%; V=F: 13%; A: 17%.Activity: S. aureus NCTC 6538 or MRSA 12,493 (MIC 4 uM), E.faecium NCTC 12,697 (MIC 128 uM), E. coli ATCC 8739 (MIC 4 uM), K. pneumoniae ATCC 43,816 (MIC 8 uM), P. aeruginosa ATCC CRM 9027 (MIC 8 uM), A. baumannii BAA 747 (MIC 16 uM), and C. albicans ATCC 10,231 (MIC 32 uM). MBC same or slightly higher.Structure: random coil in buffer NH4Ac and helical in 50% TFE.In vitro toxicity: horse RBC: HC50 41.34 uM, hemolytic.",
    "Author": "Wang J, Hu J, Pu W, Chen X, Ma C, Jiang Y, Wang T, Chen T, Shaw C, Zhou M, Wang L. 2024",
    "Reference": "Comput Struct Biotechnol J. 2024 Sep 19;23:3391-3406. doi: 10.1016/j.csbj.2024.09.006.PubMed",
    "Title": "Discovery, Development and Optimisation of a Novel Frog Antimicrobial Peptide with Combined Mode of Action Against Drug-resistant Bacteria"
  },
  "3D Structure": []
}